YTHDF3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.457600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.642000E-01
Normal-vs-Stage2
6.307600E-01
Normal-vs-Stage3
5.222100E-02
Normal-vs-Stage4
6.704000E-01
Stage1-vs-Stage2
8.178400E-01
Stage1-vs-Stage3
1.463050E-01
Stage1-vs-Stage4
4.530600E-01
Stage2-vs-Stage3
1.601760E-01
Stage2-vs-Stage4
2.444600E-01
Stage3-vs-Stage4
6.680000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.048800E-01
Normal-vs-AfricanAmerican
8.924400E-01
Normal-vs-Asian
2.937400E-01
Caucasian-vs-AfricanAmerican
3.322000E-01
Caucasian-vs-Asian
1.873040E-01
AfricanAmerican-vs-Asian
1.671790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.771000E-01
Normal-vs-Female
6.215200E-01
Male-vs-Female
9.850200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.087000E-01
Normal-vs-Age(41-60Yrs)
9.970000E-01
Normal-vs-Age(61-80Yrs)
5.510600E-01
Normal-vs-Age(81-100Yrs)
2.573800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.212800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.139400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.767200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.500000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.712400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.034400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.481600E-01
Normal-vs-Daily Drinker
2.784000E-01
Normal-vs-Weekly Drinker
4.559800E-01
Normal-vs-Occasional Drinker
9.165600E-01
Normal-vs-Social Drinker
8.997800E-01
Non Drinker-vs-Daily Drinker
5.741800E-01
Non Drinker-vs-Weekly Drinker
7.674800E-01
Non Drinker-vs-Occasional Drinker
1.700970E-01
Non Drinker-vs-Social Drinker
1.307440E-01
Daily Drinker-vs-Weekly Drinker
5.224200E-01
Daily Drinker-vs-Occasional Drinker
1.016030E-01
Daily Drinker-vs-Social Drinker
1.120220E-01
Weekly Drinker-vs-Occasional Drinker
3.576800E-01
Weekly Drinker-vs-Social Drinker
3.670800E-01
Occasional Drinker-vs-Social Drinker
9.799000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.088830E-01
Normal-vs-Grade 2
1.812000E-02
Normal-vs-Grade 3
4.000000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.608200E-01
Grade 1-vs-Grade 3
4.351400E-01
Grade 1-vs-Grade 4
1.088830E-01
Grade 2-vs-Grade 3
5.569200E-01
Grade 2-vs-Grade 4
1.812000E-02
Grade 3-vs-Grade 4
4.000000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.011400E-01
Normal-vs-NonDiabetic
5.243200E-01
Diabetic-vs-NonDiabetic
8.373600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.247400E-01
Normal-vs-NoPancreatitis
5.866400E-01
Pancreatitis-vs-NoPancreatitis
3.466200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.199200E-01
Normal-vs-N1
6.952800E-01
N0-vs-N1
5.305600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.483200E-01
Normal-vs-TP53-NonMutant
6.966400E-01
TP53-Mutant-vs-TP53-NonMutant
5.582800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
